Long-Term Immune Recovery After Hematopoietic Stem Cell Transplantation for ADA Deficiency: a Single-Center Experience

Unconditioned hematopoietic stem cell transplantation (HSCT) is the recommended treatment for patients with adenosine deaminase (ADA)-deficient severe combined immunodeficiency with an HLA-matched sibling donor (MSD) or family donor (MFD). Improved overall survival (OS) has been reported compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreins, Alexandra Y., Velasco, Helena F., Cheong, Kai-Ning, Rao, Kanchan, Veys, Paul, Worth, Austen, Gaspar, H. Bobby, Booth, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821083/
https://www.ncbi.nlm.nih.gov/pubmed/34654999
http://dx.doi.org/10.1007/s10875-021-01145-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821083/
https://www.ncbi.nlm.nih.gov/pubmed/34654999
http://dx.doi.org/10.1007/s10875-021-01145-w

Ejemplares similares